AIM (Alternative Investment Market) is the London Stock Exchange's junior market, launched in 1995. It was designed to give growth companies access to public capital with lighter regulatory requirements than the Main Market. Over three decades, it has become one of the world's most active small-cap exchanges — listing over 700 companies in sectors from mining and technology to healthcare and consumer retail.
For systematic investors, AIM is one of the most interesting hunting grounds in European equity markets. It is under-researched, has genuine information asymmetry at the small-cap end, and has historically produced strong long-term returns despite high volatility. A screener with genuine AIM coverage is the entry point to this market.
AIM in numbers
- Listed companies: approximately 700–750 (down from a peak of 1,700 in 2007)
- Total market cap: approximately £80–90 billion
- Average company size: ~£100M market cap (median is considerably lower, around £25–30M)
- Key sectors: financials, healthcare, technology, mining/resources, consumer
- Currency: GBP (sterling)
How AIM differs from the Main Market
Lighter listing requirements — Companies need a nominated adviser (Nomad) but face no minimum market cap requirement, no minimum trading history, and no minimum free float. This allows earlier-stage companies to access public capital.
Less analyst coverage — An AIM-listed company may have zero to two analysts covering it. FTSE 100 companies average 20–30 analysts. This information asymmetry is the source of opportunity.
ISA eligibility and IHT benefit (UK investors) — UK-resident investors can hold qualifying AIM shares in ISAs, sheltering returns from UK capital gains and income tax. Certain AIM shares also qualify for Business Property Relief (BPR), making them potentially exempt from UK Inheritance Tax after two years. This creates a structural and recurring buying class for AIM shares.
Variable transaction costs — Bid-ask spreads range from near-zero on liquid AIM names to 3–8% on illiquid micro-caps. Always check liquidity before screening position sizes on smaller AIM companies.
Nomad-regulated governance — AIM is regulated differently from the Main Market. The Nomad system delegates oversight. This is a feature for growth companies seeking lighter oversight, but requires more investor due diligence on governance quality.
Sectors worth screening on AIM
Healthcare and life sciences
AIM has a well-developed healthcare and biotech cluster. The lighter regulatory requirements allow earlier-stage clinical companies to list. For biotech, traditional fundamental screening is less useful than pipeline analysis. For established (non-biotech) healthcare companies on AIM:
- Net margin > 5%
- Revenue growth > 10% YoY
- Debt/Equity < 0.5
Technology
AIM hosts a range of software and tech businesses across fintech, cybersecurity, SaaS, and legacy IT services. The sector contains genuinely disruptive companies alongside legacy operators at depressed valuations. The two require different screening approaches.
For AIM SaaS and recurring-revenue tech:
- Revenue growth > 15% YoY
- Gross margin > 50%
- Annual Recurring Revenue (ARR) growth where available
For AIM legacy tech at value:
- P/E below 10
- Free cash flow yield > 8%
- Shrinking revenue < 5% (i.e. not in freefall)
Resources — oil, gas, mining
AIM's resource sector is large and volatile. It spans producing companies with real cash flows and junior exploration companies with nothing but a licence and ambition. Screen them differently.
For producers:
- EV/EBITDA < 5x
- Reserves life > 5 years
- Net debt/EBITDA < 2x
For explorers: fundamental screening is largely inapplicable. Position sizing and geological due diligence matter more than financial ratios.
Consumer and retail
Some of AIM's most interesting value situations are in consumer and retail: established businesses that have fallen out of investor favour due to sector headwinds but remain operationally sound. Classic contrarian value territory.
Building an AIM screen: step by step
The challenge with AIM is data quality. For sub-£20M market cap companies, fundamental data is often incomplete or updated with a lag. A practical screen accounts for this.
Step 1: Set a liquidity floor
AIM micro-caps can have days of zero volume. Set a minimum to ensure tradeable positions:
- Average daily turnover > £25,000 (or average daily volume > 50,000 shares)
Step 2: Market cap range
Focus where fundamental data is most reliable:
- For value and dividend focus: £20M–£500M
- For growth focus: £10M–£200M
Step 3: Profitability filter (exclude pre-revenue and exploration names)
- Operating profit > 0 (positive operating income in the most recent year)
- Gross margin > 20%
Step 4: Choose a strategy direction
Value screen:
- P/E < 12
- EV/EBITDA < 7
- Dividend yield > 3%
Growth screen:
- Revenue growth > 15%
- Gross margin expanding year-over-year
- Net cash (no debt, or net cash position)
Step 5: Financial health
- Current ratio > 1.0
- Debt/Equity < 1.0 (except financial companies)
The IHT advantage: how it affects AIM valuations
For UK investors, the Business Property Relief (BPR) qualification creates a structural bid for qualifying AIM shares. Investors who hold qualifying AIM shares for two or more years can pass them to heirs without UK Inheritance Tax (currently 40%). With UK estate values rising and BPR being one of the few remaining IHT exemptions, wealth managers have created dedicated AIM IHT portfolios.
This structural demand supports valuations of profitable, qualifying AIM companies — particularly in sectors like engineering, media, and consumer businesses. Understanding this helps explain why some AIM companies trade at premiums to comparable Main Market peers with similar fundamentals.
AIM vs. European small-cap alternatives
| Market | Listed Companies | Key Sectors | Tax Advantage |
|---|---|---|---|
| AIM (London) | ~730 | Tech, healthcare, resources | IHT/ISA (UK residents) |
| First North (Nordic) | ~450 | Tech, healthcare, consumer | None specific |
| EGM (Italy) | ~200 | Industrial, consumer | PIR plans (Italy) |
| Euronext Growth (Paris) | ~180 | Tech, industrial | PEA-PME (France) |
| Scale (Germany) | ~100 | Tech, industrial | None specific |
AIM remains the largest and most liquid junior exchange in Europe by traded value, even after the contraction from its 2007 peak.
Risks specific to AIM investing
Governance risk — The lighter regulatory framework produces occasional governance failures. Always check director track record, share issuance history, and related-party transactions.
Nomad loss risk — Companies that lose their Nomad must find a replacement within one month or face suspension. Nomad changes are an early warning signal worth monitoring.
Liquidity risk — Below £10M market cap, selling a meaningful position can move the market significantly. Size positions relative to daily volume, not just portfolio weight.
Fundraising dilution — Many AIM companies return to market regularly for additional capital (placings, open offers). Check the 5-year share count history when evaluating return metrics. Companies that have diluted shareholders by 50%+ over five years will show misleading per-share metrics.
Conclusion
AIM is one of the most genuinely inefficient markets accessible to individual investors. The combination of limited analyst coverage, structural tax complexity, and the perceived difficulty of dealing in a junior market creates persistent pricing gaps. A screener with genuine AIM coverage — including fundamental data across the full market, not just the largest AIM names — is the starting point for exploiting this inefficiency systematically.